Method and apparatus for monitoring the condition of a patient with diabetes
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61M-015/08
A61M-016/06
A61M-016/00
출원번호
US-0997976
(2007-02-16)
등록번호
US-8640698
(2014-02-04)
우선권정보
AU-2006900780 (2006-02-17)
국제출원번호
PCT/AU2007/000172
(2007-02-16)
§371/§102 date
20080205
(20080205)
국제공개번호
WO2007/093010
(2007-08-23)
발명자
/ 주소
Darkin, Donald
Schindhelm, Klaus Henry
Harrington, Carmel Therese
출원인 / 주소
RedMed Limited
대리인 / 주소
Nixon & Vanderhye PC
인용정보
피인용 횟수 :
4인용 특허 :
19
초록▼
According to certain example embodiments of this invention, there is provided an apparatus for treatment of a patient with both sleep-disordered breathing and diabetes. A PAP device may be configured to provide a supply of pressurized breathable gas. At least one glycemia sensor also may be provided
According to certain example embodiments of this invention, there is provided an apparatus for treatment of a patient with both sleep-disordered breathing and diabetes. A PAP device may be configured to provide a supply of pressurized breathable gas. At least one glycemia sensor also may be provided. A controller may be operable to receive a signal from the at least one glycemia detector and may be further operable to analyze the signal for an indication of a glycemia abnormality (e.g., hypoglycemia, hyperglycemia, diabetic coma, etc.). Optionally, when the signal indicates that the patient is experiencing a diabetic event, an alert may be generated and/or a drug delivery unit may administer an appropriate treatment to the patient.
대표청구항▼
1. An apparatus for treatment of a patient with both sleep-disordered breathing and diabetes, comprising: a blower configured to provide a supply of air at positive pressure;a patient interface including a mask;headgear adapted to hold the patient interface in position in communication with a patien
1. An apparatus for treatment of a patient with both sleep-disordered breathing and diabetes, comprising: a blower configured to provide a supply of air at positive pressure;a patient interface including a mask;headgear adapted to hold the patient interface in position in communication with a patient's airways;at least one hypoglycemia detector including a sensor for contact with mucosal regions of the patient's nares on a nasal prong of the mask;an alarm; anda controller,wherein the controller is programmed to receive a signal from the at least one hypoglycemia detector, analyze the signal for indications of hypoglycemia and, upon detection of an indication of hypoglycemia, trigger the alarm. 2. The apparatus according to claim 1, wherein said at least one hypoglycemia detector is further configured to detect activation of the sympathetic nervous system. 3. The apparatus according to claim 1, wherein said at least one hypoglycemia detector is further configured to detect at least one of: patient sweating, temperature, heart rate, and respiration rate. 4. The apparatus according to claim 1, further comprising a flow sensor in fluid communication with the patient interface. 5. The apparatus according to claim 1, wherein said alarm is a buzzer. 6. The apparatus according to claim 1 wherein said alarm is sent to a remote monitoring system. 7. An apparatus for treatment of a patient with both sleep-disordered breathing and diabetes, comprising: a PAP device configured to provide a supply of pressurized breathable gas;at least one glycemia detector built into a mask system connected to the PAP device; and,a controller operable to receive a signal from the at least one glycemia detector and further operable to analyze the signal for an indication of a glycemia abnormality,wherein the at least one glycemia detector further includes: a transcutaneous blood sugar level detector, a sensor for contact with mucosal regions of the patient nares on a nasal prong of a mask connected to the PAP device, and/or a sensor configured to measure the patient's glucose level by extracting a small amount of interstitial fluid that has been removed from between the skin cells via a vacuum tube. 8. The apparatus according to claim 7, wherein said at least one glycemia detector is further configured to detect activation of the sympathetic nervous system. 9. The apparatus according to claim 7, wherein said at least one glycemia detector is further configured to detect at least one of: patient sweating, temperature, heart rate, and respiration rate. 10. The apparatus according to claim 7, wherein the controller is further operable to sound an audible alert when the signal indicates a glycemia abnormality. 11. The apparatus according to claim 7, wherein the controller is further operable to send information about the patient treatment to a remote monitoring station. 12. The apparatus according to claim 11, wherein the controller is configured to send the information when the signal indicates one or more of: patient hypoglycemia, hyperglycemia, and/or diabetic coma. 13. The apparatus according to claim 7, further comprising a drug delivery unit. 14. The apparatus according to claim 13, wherein the drug delivery unit is configured to supply glucose and/or insulin to the patient. 15. A method of treating a patient with both sleep-disordered breathing and diabetes, the method comprising: providing a supply of pressurized breathable gas to the patient; and,generating a signal indicative of whether the patient is experiencing a diabetic event, the signal being based on data gathered from (a) a first sensor in contact with mucosal regions of the patient's nares on a nasal prong of a mask connected to a PAP device used in providing the supply of pressurized breathable gas to the patient, and (b) a second sensor built into headgear that is adapted to hold the mask in a position suitable for communicating the supply of pressurized breathable gas to the patient's airways. 16. The method according to claim 15, further comprising when the signal indicates that the patient is experiencing a diabetic event, activating an alert mechanism. 17. The method according to claim 16, wherein the activating of the alert mechanism is further practiced by sounding an audible alarm. 18. The method according to claim 16, wherein the activating of the alert mechanism is further practiced by notifying a remote monitoring station. 19. The method according to claim 15, further comprising when the signal indicates that the patient is experiencing a diabetic event, administering a corresponding treatment. 20. The apparatus according to claim 7, wherein the at least one glycemia detector is built into headgear that is adapted to hold the mask in a position suitable for communicating the supply of pressurized breathable gas to the patient's airways. 21. The apparatus according to claim 7, wherein the at least one glycemia detector includes a sensor for contact with mucosal regions of the patient nares on a nasal prong of a mask connected to the PAP device. 22. An apparatus for treatment of a patient with both sleep-disordered breathing and diabetes, comprising: a PAP device including a controller, the PAP device being configured to provide a supply of air at positive pressure at 4-20 cmH2O;a patient interface;headgear adapted to hold the patient interface in position in communication with a patient's airways;at least one hypoglycemia detector, wherein the at least one hypoglycemia detector includes a sensor for contact with mucosal regions of the patient nares on a nasal prong of the patient interface connected to the PAP device; andan alarm;wherein the controller included in the PAP device is programmed to receive a signal from the at least one hypoglycemia detector, analyze the signal for indications of hypoglycemia and, upon detection of an indication of hypoglycemia, trigger the alarm. 23. An apparatus for treatment of a patient with both sleep-disordered breathing and diabetes, comprising: a PAP device configured to provide a supply of pressurized breathable gas at one or more sleep-disordered breathing treatment pressures in a range of 4-20 cmH2O;at least one glycemia detector, wherein the at least one glycemia detector includes a sensor for contact with mucosal regions of the patient nares on a nasal prong of a patient interface connected to the PAP device;an action unit including a drug delivery unit for use in treating the patient's diabetes; anda controller integrated into the PAP device and operable to receive a signal from the at least one glycemia detector, analyze the signal for an indication of a glycemia abnormality, and instruct the drug delivery unit to provide a treatment to the patient for the glycemia abnormality while also instructing the PAP device to provide the supply of pressurized breathable gas. 24. The apparatus according to claim 23, wherein the drug delivery unit is configured to provide oral insulin and/or glucose to the patient upon receiving instructions from the controller. 25. The apparatus according to claim 23, wherein the drug delivery unit is configured to provide the treatment to the patient for the glycemia abnormality in vapor form and/or through aerosol delivery. 26. The apparatus according to claim 23, wherein the drug delivery unit is configured to provide insulin and/or glucose to the patient in vapor form and/or through aerosol delivery upon receiving instructions from the controller.
Melker,Richard J.; Gravenstein,Joachim S.; Worley,George, Specially configured nasal pulse oximeter/photoplethysmography probes, and combined nasal probe/cannula, selectively with sampler for capnography, and covering sleeves for same.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.